Melanocortin receptor research
PT-141.
5 vendors · €18–43
Cyclic melanocortin-receptor agonist derived from α-MSH. The active molecule in Vyleesi (FDA-approved 2019, prescription-only for HSDD); research-peptide formulations are sold under research-use-only labelling and are not approved for human therapeutic use.
Live vendor register · sorted by price
Every vendor. Same compound, sorted ascending.
PT-141 · price-normalised
n = 5 vendors
01
QSC Peptides
VID-QSC-PEPTHPLC · MS · Janoshik
99%
3–7 days (EU warehouse) · Kit of 10 · from $210 USD
€18
02
Direct Peptides EU
VID-DIRECT-PNo public testing info
99%
10–14 days · UK network · from £21.45
€25
03
PeptidesDirect
VID-PEPTIDESHPLC · MS (per-batch COA)
99.91%
DE 1–2 d · EU 3–10 d · DE dispatch
€34
Long-form research guide
Reproductive Health Research. Mechanism + protocols + safety.
Melanocortin receptor pharmacology and sexual behaviour in preclinical models
Open the long-form guide for PT-141 →